Viewing StudyNCT06450106

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06450106
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-10
First Post: 2024-06-02
Brief Title: Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Sponsor: SURGE Therapeutics
Organization: SURGE Therapeutics
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Hydrogel View
Intraoperative View
Dose escalation View
Open-label View
STM-416 View
Resiquimod View
Toll-like receptor 78 View
Radical prostatectomy View
Robotic prostatectomy View
Immunotherapy View
STM-416p View
PSA View
R848 View